| Literature DB >> 29393004 |
Rosalyn Singleton1,2, Aaron J Salkoski3, Lisa Bulkow4, Chris Fish5, Jennifer Dobson6, Leif Albertson7, Jennifer Skarada8, Troy Ritter9, Thomas Kovesi10, Thomas W Hennessy11.
Abstract
Alaska Native children experience high rates of lower respiratory tract infections (LRTIs) and lung conditions, which are associated with substandard indoor air quality (IAQ). We conducted an intervention of home remediation and education to assess the impact on IAQ, respiratory symptoms and LRTI visits. We enrolled households of children 1-12 years of age with lung conditions. Home remediation included improving ventilation and replacing leaky woodstoves. We provided education about IAQ and respiratory health. We monitored indoor airborne particles (PM2.5), CO2, relative humidity and volatile organic compounds (VOCs), and interviewed caregivers about children's symptoms before, and for 1 year after intervention. We evaluated the association between children's respiratory visits, symptoms and IAQ indicators using multiple logistic regression. A total of 60 of 63 homes completed the study. VOCs decreased (coefficient = -0.20; p < 0.001); however, PM2.5 (coeff. = -0.010; p = 0.89) did not decrease. Burning wood for heat, VOCs and PM2.5 were associated with respiratory symptoms. After remediation, parents reported decreases in runny nose, cough between colds, wet cough, wheezing with colds, wheezing between colds and school absences. Children had an age-adjusted decrease in LRTI visits (coefficient = -0.33; p = 0.028). Home remediation and education reduced respiratory symptoms, LRTI visits and school absenteeism in children with lung conditions.Entities:
Keywords: Alaska Native; air pollution; children; indoor; lung diseases; volatile organic compounds
Mesh:
Substances:
Year: 2018 PMID: 29393004 PMCID: PMC5804775 DOI: 10.1080/22423982.2017.1422669
Source DB: PubMed Journal: Int J Circumpolar Health ISSN: 1239-9736 Impact factor: 1.228
Indoor air quality measurements pre- and post-remediation in study homes in southwest Alaska, 2011–2016.
| Indoor air measurement | Baseline | Post remediation** | 1 year after baseline | Random intercept | |
|---|---|---|---|---|---|
| Total VOCs (µg/m3) | GMC (95% CI) | 107 (79, 145) | 94 (74, 121) | 78 (64, 96) | |
| Median | 99 | 89 | 61 | ||
| BTEX VOCs (µg/m3) | GMC (95% CI) | 53 (37, 77) | 49 (36, 66) | 32 (24, 44) | |
| Median | 45 | 44 | 29 | ||
| BTEX/Total VOC (%) | Mean (95% CI) | 51% (45%, 56%) | 52% (47%, 56%) | 43% (37%, 49%) | |
| Median | 49% | 50% | 43% | ||
| PM2.5 (µg/m3) | GMC (95% CI) | 12.0 (9.4, 15.2) | 12.1 (9.2, 15.9) | 12.3 (9.7, 15.6) | −0.010 (0.890) |
| Median | 18 | 22 | 15 | ||
| CO2***(ppm) | GMC (95% CI) | 1379 (1194, 1592) | 1243 (1117, 1384) | 1466 (1248, 1722) | 0.027 (0.288) |
| Median | 1401 | 1264 | 1418 | ||
| RH (%) | Mean (95% CI) | 35.9 (33.0, 38.9) | 34.5 (31.5, 37.6) | 42.7 (39.4, 46.0) | |
| Median | 35.6 | 32.6 | 42.8 |
* Values are assessed with a linear mixed model (by home) on the log transformed values. Per coded as (1,2,3).
** Post remediation is 1–2 months after baseline.
*** Years 2–4.
The bold values are significant with a p-value <0.05
VOC measurements are one summary over 4 days of collection, PM2.5, CO2 and RH are mean (RH) and GMC (PM2.5, CO2) from multiple measurements over the 4 days. Carbon monoxide was measured in years 2–4. 98% of levels (118/121) were <5 ppm, the remaining 3 levels were all <20 ppm.
VOC: volatile organic compounds; GMC: geometric mean concentration; PM2.5: small airway particles; RH: relative humidity; BTEX: total of benzene, toluene, ethylbenzene, o-xylene and m,p-xylene.
Coefficients from linear (Ln) models of indoor air quality on time periods after remediation and possible confounding factors in southwest Alaska homes before and after interventions, 2011–2016.
| | Coefficient (p-value) | |||||||
|---|---|---|---|---|---|---|---|---|
| Time period | | |||||||
| 2 | 3 | Smoking | Woodstove use | Avg num slept in HH | Outdoor air temp | Piped water | ||
| Ln(Total VOC) | Univariate | −0.14 | −0.036 (0.865) | 0.035 (0.798) | ||||
| Multivariate | −0.14 | 0.041 (0.833) | 0.059 (0.638) | −0.005 (0.161) | ||||
| Ln(BTEX) | Univariate | −0.069 (0.801) | 0.29 (0.101) | |||||
| Multivariate | −0.006 (0.981) | −0.005 (0.245) | ||||||
| Ln(PM2.5) | Univariate | −0.016 | −0.019 (0.989) | −0.002 (0.562) | 0.016 (0.934) | |||
| Multivariate | −0.051 | −0.003 (0.909) | −0.001 (0.774) | 0.043 (0.821) | ||||
| Ln(CO2) | Univariate | −0.008 (0.924) | −0.090 (0.135) | 0.0004 (0.763) | ||||
| Multivariate | 0.052 (0.474) | −0.048 (0.349) | 0.0008 (0.556) | |||||
| % BTEX | Univariate | 0.023 (0.638) | ||||||
| Multivariate | −0.019 (0.649) | −0.001 (0.427) | ||||||
| Avg RH | Univariate | 1.11 (0.691) | 1.11 (0.662) | |||||
| Multivariate | 1.33 (0.544) | −1.85 (0.197) | −2.79 (0.241) | |||||
Household smoking during the air quality sampling period occurred 12% (18/153 sampling periods) of the time, wood stove use occurred 33% (50/153) of the time and 55% (33/60) of the homes had piped water. The average number of people sleeping in the home was 6.7 and the median outdoor air temperature was 16.4°F (min −10.5°F, max 39.4°F).
The bold values are significant with a p-value <0.05
VOC: volatile organic compounds; PM2.5: small airway particles; RH: relative humidity; BTEX: total of benzene, toluene, ethylbenzene, o-xylene and m,p-xylene; Avg Num slept in HH: average number of people sleeping in the home.
Parent-reported respiratory symptoms on an interval questionnaire adjusted for age category and season; high-risk status as factor, in Alaska study homes, before and after household interventions, 2011–2016. No interactions between high-risk and post- intervention are significant.
| Pre | Post | |||||
|---|---|---|---|---|---|---|
| Post | ||||||
| Initial visit | Pre-intervention | 2-weeks post | 3-months post | 1-year post | Odds Ratio | |
| Cold or runny nose? | 118 (58%) | 111 (55%) | 83 (42%) | 80 (46%) | 64 (41%) | |
| Any cough between colds? | 74 (36%) | 86 (43%) | 60 (30%) | 58/173 (34%) | 39/154 (25%) | |
| Any wet cough? | 51/202 (25%) | 42/202 (21%) | 33/197 (17% | 45/173 (20%) | 19/152 (13%) | |
| Any wheezing or whistling? | 36/202 (18%) | 31/202 (15%) | 26 (12%) | 29/172 (17%) | 12/152 (8%) | 0.60 (0.057) |
| Any wheezing between colds? | 22 (11%) | 10 (5%) | 3 (2%) | 5 (3%) | 6 (4%) | |
| Any wheezing attack? | 7 (3%) | 11 (5%) | 3 (2%) | 5 (3%) | 6 (4%) | 0.73 (0.497) |
| Needed inhaler or nebuliser? | 42/203 (21%) | 35/202 (17%) | 23/197 (12%) | 32/172 (19%) | 15/153 (10%) | |
| Any missed school for illness? | 23/138 (17%) | 19/127 (15%) | 13/132 (10%) | 6/67 (9%) | 3/112 (3%) | |
The bold values are significant with a p-value <0.05
Matched comparison of healthcare visits in all household children and adults, in Alaska study homes before and after household interventions, 2011–2016.
| Children | Adults* | ||||||
|---|---|---|---|---|---|---|---|
| Pre** | Post | p-value*** | Pre | Post | p-value | ||
| N | 182 | 79 | |||||
| All Visits | Mean (±SE)**** | 13.6 (±0.77) | 11.2 (±0.64) | 10.5 (±1.24) | 11.3 (±1.57) | 0.578 | |
| Median | 11.5 | 9 | 7 | 8 | 0.833 | ||
| ARI | Mean (±SE) | 6.99 (±0.57) | 5.24 (±0.43) | 2.41 (±0.37) | 2.25 (±0.36) | 0.574 | |
| Median | 4 | 3.5 | 1 | 1 | 0.532 | ||
| LRTI | Mean (±SE) | 1.91 (±0.25) | 1.36 (±0.19) | 0.72 (±0.19) | 0.49 (±0.15) | 0.095 | |
| Median | 0 | 0 | 0 | 0 | 0.119 | ||
| Antibiotic | Mean (±SE) | 4.05 (±0.31) | 4.01 (±0.31) | 0.902 | 2.71 (±0.46) | 3.06 (±0.41) | 0.448 |
| Median | 3 | 3 | 0.611 | 1 | 2 | 0.093 | |
| Albuterol | Mean (±SE) | 1.84 (±0.21) | 2.64 (±0.30) | 1.90 (±0.46) | 1.75 (±0.41) | 0.763 | |
| Median | 1 | 1 | 0.075 | 0 | 0 | 0.827 | |
| Asthma Rx | Mean (±SE) | 2.02 (±0.23) | 2.88 (±0.31) | 2.13 (±0.48) | 1.91 (±0.42) | 0.672 | |
| Median | 1 | 1 | 0 | 0 | 0.578 | ||
* Adult data are available for 3 villages from years 3 and 4.
** Pre and Post periods are 1 year in length except for year 1 villages where the period is 8 months.
*** p-values are calculated with a matched t-test (mean) and signrank test (median).
**** SE: Standard error of the mean.
The bold values are significant with a p-value <0.05
ARI: acute respiratory infections; LRTI: lower respiratory tract infections; Rx: prescription.
Poisson regression of number of visits pre- and post-household interventions, using random effects model with random effect for person, for children in study households, 2011–2016.
| High-risk children | Other household children | All children | ||||
|---|---|---|---|---|---|---|
| Coefficient (95% CI) | Coefficient (95% CI) | Coefficient (95% CI) | ||||
| Adj* | Adj* | Adj* | ||||
| All Visits | ||||||
| All | 0.03 | −0.012 | ||||
| ARI | −0.13 | 0.09 | 0.02 | |||
| LRTI | −0.02 | 0.67 | 0.16 | |||
| Antibiotic Rx | 0.02 | 0.09 | −0.01 | |||
| Albuterol Rx | 0.19 | |||||
| Asthma Rx | ||||||
*Adjusted model includes adjustment for age as three linear splines (<2, 2–3, 4–13 years).
Includes participants available for entire pre and post periods.
The bold values are significant with a p-value <0.05
LRTI: lower respiratory tract infection; ARI: acute respiratory infection; Rx: prescription.